Till Schellhorn1,2, Eva Birgitte Aamodt3,4, Stian Lydersen5, Stina Aam6,7, Torgeir Bruun Wyller4,8, Ingvild Saltvedt6,7, Mona Kristiansen Beyer3,4. 1. Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. tillsc@uio.no. 2. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. tillsc@uio.no. 3. Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. 4. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 5. Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. 6. Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. 7. Department of Geriatric Medicine, Clinic of Medicine St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. 8. Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
Abstract
BACKGROUND: Neurocognitive disorder (NCD) is common in stroke survivors. We aimed to identify clinically accessible imaging markers of stroke and chronic pathology that are associated with early post-stroke NCD. METHODS: We included 231 stroke survivors from the "Norwegian Cognitive Impairment after Stroke (Nor-COAST)" study who underwent a standardized cognitive assessment 3 months after the stroke. Any NCD (mild cognitive impairment and dementia) and major NCD (dementia) were diagnosed according to "Diagnostic and Statistical Manual of Mental Disorders (DSM-5)" criteria. Clinically accessible imaging findings were analyzed on study-specific brain MRIs in the early phase after stroke. Stroke lesion volumes were semi automatically quantified and strategic stroke locations were determined by an atlas based coregistration. White matter hyperintensities (WMH) and medial temporal lobe atrophy (MTA) were visually scored. Logistic regression was used to identify neuroimaging findings associated with major NCD and any NCD. RESULTS: Mean age was 71.8 years (SD 11.1), 101 (43.7%) were females, mean time from stroke to imaging was 8 (SD 16) days. At 3 months 63 (27.3%) had mild NCD and 65 (28.1%) had major NCD. Any NCD was significantly associated with WMH pathology (odds ratio (OR) = 2.73 [1.56 to 4.77], p = 0.001), MTA pathology (OR = 1.95 [1.12 to 3.41], p = 0.019), and left hemispheric stroke (OR = 1.8 [1.05 to 3.09], p = 0.032). Major NCD was significantly associated with WMH pathology (OR = 2.54 [1.33 to 4.84], p = 0.005) and stroke lesion volume (OR (per ml) =1.04 [1.01 to 1.06], p = 0.001). CONCLUSION: WMH pathology, MTA pathology and left hemispheric stroke were associated with the development of any NCD. Stroke lesion volume and WMH pathology were associated with the development of major NCD 3 months after stroke. These imaging findings may be used in the routine clinical setting to identify patients at risk for early post-stroke NCD. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02650531 , Registered 8 January 2016 - Retrospectively registered.
BACKGROUND:Neurocognitive disorder (NCD) is common in stroke survivors. We aimed to identify clinically accessible imaging markers of stroke and chronic pathology that are associated with early post-stroke NCD. METHODS: We included 231 stroke survivors from the "Norwegian Cognitive Impairment after Stroke (Nor-COAST)" study who underwent a standardized cognitive assessment 3 months after the stroke. Any NCD (mild cognitive impairment and dementia) and major NCD (dementia) were diagnosed according to "Diagnostic and Statistical Manual of Mental Disorders (DSM-5)" criteria. Clinically accessible imaging findings were analyzed on study-specific brain MRIs in the early phase after stroke. Stroke lesion volumes were semi automatically quantified and strategic stroke locations were determined by an atlas based coregistration. White matter hyperintensities (WMH) and medial temporal lobe atrophy (MTA) were visually scored. Logistic regression was used to identify neuroimaging findings associated with major NCD and any NCD. RESULTS: Mean age was 71.8 years (SD 11.1), 101 (43.7%) were females, mean time from stroke to imaging was 8 (SD 16) days. At 3 months 63 (27.3%) had mild NCD and 65 (28.1%) had major NCD. Any NCD was significantly associated with WMH pathology (odds ratio (OR) = 2.73 [1.56 to 4.77], p = 0.001), MTA pathology (OR = 1.95 [1.12 to 3.41], p = 0.019), and left hemispheric stroke (OR = 1.8 [1.05 to 3.09], p = 0.032). Major NCD was significantly associated with WMH pathology (OR = 2.54 [1.33 to 4.84], p = 0.005) and stroke lesion volume (OR (per ml) =1.04 [1.01 to 1.06], p = 0.001). CONCLUSION:WMH pathology, MTA pathology and left hemispheric stroke were associated with the development of any NCD. Stroke lesion volume and WMH pathology were associated with the development of major NCD 3 months after stroke. These imaging findings may be used in the routine clinical setting to identify patients at risk for early post-stroke NCD. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02650531 , Registered 8 January 2016 - Retrospectively registered.
Entities:
Keywords:
Cognitive impairment; Post stroke dementia; Stroke imaging; Stroke volume; White matter lesions
Authors: Adam M Brickman; Laura B Zahodne; Vanessa A Guzman; Atul Narkhede; Irene B Meier; Erica Y Griffith; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Richard Mayeux Journal: Neurobiol Aging Date: 2014-07-21 Impact factor: 4.673
Authors: E A Mistry; A M Mistry; T Mehta; N Arora; A K Starosciak; F D L R La Rosa; J E Siegler; S E Kasner; R Chitale; M Fusco; M Froehler; S Yaghi; M Schrag; P Khatri Journal: AJNR Am J Neuroradiol Date: 2020-03-12 Impact factor: 3.825
Authors: Kristian Nygaard Mortensen; Simon Sanggaard; Humberto Mestre; Hedok Lee; Serhii Kostrikov; Anna L R Xavier; Albert Gjedde; Helene Benveniste; Maiken Nedergaard Journal: J Neurosci Date: 2019-06-17 Impact factor: 6.167
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: H J Kim; B S Ye; C W Yoon; Y Noh; G H Kim; H Cho; S Jeon; J M Lee; J-H Kim; J-K Seong; C-H Kim; Y S Choe; K H Lee; S T Kim; J S Kim; S E Park; J-H Kim; J Chin; J Cho; C Kim; J H Lee; M W Weiner; D L Na; S W Seo Journal: Eur J Neurol Date: 2014-02-04 Impact factor: 6.089
Authors: P Scheltens; D Leys; F Barkhof; D Huglo; H C Weinstein; P Vermersch; M Kuiper; M Steinling; E C Wolters; J Valk Journal: J Neurol Neurosurg Psychiatry Date: 1992-10 Impact factor: 10.154
Authors: Eva B Aamodt; Stian Lydersen; Dag Alnæs; Till Schellhorn; Ingvild Saltvedt; Mona K Beyer; Asta Håberg Journal: Front Neurol Date: 2022-06-03 Impact factor: 4.086